covid 19 News and Research

RSS

Researchers investigate how pollen facilitates the spread of COVID-19 virus

Most models explaining how viruses are transmitted focus on viral particles escaping one person to infect a nearby person. A study on the role of microscopic particles in how viruses are transmitted suggests pollen is nothing to sneeze at.

22 Jun 2021

Using environmental fluid dynamics to correct COVID-19 pandemic's first wave data inaccuracies

Two COVID-19 pandemic curves emerged within many cities during the one-year period from March 2020 to March 2021.

22 Jun 2021

New universal vaccine protects mice against COVID-19 and other coronaviruses

Scientists at the University of North Carolina Gillings School of Global Public Health have developed a universal vaccine that protected mice not just against COVID-19 but also other coronaviruses and triggered the immune system to fight off a dangerous variant.

22 Jun 2021

Engineering nanobodies to fight against the SARS-CoV-2 virus

Scientists are pursuing a new strategy in the protracted fight against the SARS-CoV-2 virus by engineering nanobodies that can neutralize virus variants in two different ways.

22 Jun 2021

Do the Moderna and Pfizer COVID-19 vaccines elicit different antibody responses?

A recent study led by scientists from the United States has compared the anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody response among clinicians who have been immunized with Pfizer/BioNTech or Moderna coronavirus disease 2019 (COVID-19) vaccine.

22 Jun 2021

What is the optimal dosing regimen for remdesivir in COVID-19 patients? A computational model

A team of scientists from the Pennsylvania State University, USA, recently analyzed the pharmacodynamics and pharmacokinetics of antiviral drug remdesivir using computational models. Based on the study findings, which are yet to be peer-reviewed, the scientists recommend that for effective inhibition of SARS-CoV-2 infection, remdesivir should be used with other antiviral medicines, or its dosing regimen should be optimized to improve bioavailability.

22 Jun 2021

Is liquid chalk an effective disinfectant of SARS-CoV-2 and influenza viruses?

A recent study, published in the American Society for Microbiology’s journal, mSphere, evaluated the use of many liquid chalk products as antiseptics against the transmission of highly pathogenic human viruses such as influenza A virus (H1N1), SARS-CoV-2, (IAV), and norovirus in a mouse norovirus (MNV) model. The researchers applied chalk before or after virus inoculum and determined the recovery of infectious virus to mimic its use in the gym setting.

22 Jun 2021

Have maternal pre-pandemic stress levels influenced children’s mental health during the COVID-19 pandemic?

A recent study, published in Child and Adolescent Psychiatry and Mental Health, assessed the role of maternal daily perceived stress on the mental health of children during the pandemic.

22 Jun 2021

Researchers screen Chinese herbal medicines and plant compounds for anti-SARS-CoV-2 activity

A review published in Phytotherapy Research discussed the natural anti-SARS-CoV-2 products identified based on in silico prediction. The review’s authors also illustrate the impact of many phytochemicals either alone or in combination with traditional treatments and their potential molecular mechanisms involved in SARS-CoV-2 prevention and treatment.

22 Jun 2021

Is Rand Paul mixing up the vaccine message for Covid survivors?

Last week, Sen. Rand Paul (R-Ky.) posted a Twitter thread asserting that people who have survived a Covid-19 infection were unlikely to be reinfected and have better immunity against variants than those who have been vaccinated against — but not infected by — SARS-CoV-2, the virus that causes Covid.

22 Jun 2021

Hospitals, insurers invest big dollars to tackle patients’ social needs

When doctors at a primary care clinic here noticed many of its poorest patients were failing to show up for appointments, they hoped giving out free rides would help.

22 Jun 2021

The effect of novel insertion mutation in SARS-CoV-2 spike glycoprotein RNA

In a recent study, a group of researchers discuss the functional implications of this specific S protein mutation on SARS-CoV-2.

22 Jun 2021

Bruker’s molecular phenomics research tools enable new insights into ‘long COVID’ and post-acute metabolic abnormalities

A clinical research collaboration on COVID-19 pheno-conversion and subsequent pheno-reversion has discovered transient and persistent systemic changes of the molecular signatures in patient blood samples three months after the acute COVID-19 disease phase.

From Bruker BioSpin Group 22 Jun 2021

Does SARS-CoV-2 alter the expression of molecules involved in the homeostasis of blood pressure?

A recent study finds that COVID-19 alters the expression of several molecules involved in the homeostasis of blood pressure.

22 Jun 2021

Use of nanotherapeutics in treating coronavirus diseases

Despite advancements in medicine, viral infections still pose a huge threat to human health and are a significant concern for global public health systems.

22 Jun 2021

Coronaviruses identified in two species of Sri Lankan bats

Researchers sampled different species of bats roosting in the Wavul Galge cave in Sri Lanka and found two species harboring alpha- and beta-coronaviruses.

22 Jun 2021

Single-dose of COVID-19 mRNA vaccine reduces symptom duration

A study of workers administered the first dose of the BNT162b2 vaccine showed that they had reduced symptoms and faster viral clearance within six days of administration.

22 Jun 2021

Birthday parties may have boosted infection rates at the height of the COVID-19 pandemic

The link between birthdays and COVID-19 could explain higher infections in counties that did not prevent such gatherings.

22 Jun 2021

New tool exposes deeply entrenched inequities in COVID-19 outcomes

The Urban Health Collaborative, housed in Drexel University's Dornsife School of Public Health, recently published its "COVID-19 Health Inequities in Cities" dashboard - which exposes deeply entrenched inequities in cities across the United States through the lens of comprehensive data on COVID-19 outcomes.

22 Jun 2021

Clinicians report cases of rare neurological disorder following COVID-19 vaccination

In two separate articles in the Annals of Neurology, clinicians in India and England report cases of a rare neurological disorder called Guillain-Barre? syndrome after individuals were vaccinated against COVID-19.

22 Jun 2021

covid 19 News and Research

Researchers investigate how pollen facilitates the spread of COVID-19 virus

Using environmental fluid dynamics to correct COVID-19 pandemic's first wave data inaccuracies

New universal vaccine protects mice against COVID-19 and other coronaviruses

Engineering nanobodies to fight against the SARS-CoV-2 virus

Do the Moderna and Pfizer COVID-19 vaccines elicit different antibody responses?

What is the optimal dosing regimen for remdesivir in COVID-19 patients? A computational model

Is liquid chalk an effective disinfectant of SARS-CoV-2 and influenza viruses?

Have maternal pre-pandemic stress levels influenced children’s mental health during the COVID-19 pandemic?

Researchers screen Chinese herbal medicines and plant compounds for anti-SARS-CoV-2 activity

Is Rand Paul mixing up the vaccine message for Covid survivors?

Hospitals, insurers invest big dollars to tackle patients’ social needs

The effect of novel insertion mutation in SARS-CoV-2 spike glycoprotein RNA

Bruker’s molecular phenomics research tools enable new insights into ‘long COVID’ and post-acute metabolic abnormalities

Does SARS-CoV-2 alter the expression of molecules involved in the homeostasis of blood pressure?

Use of nanotherapeutics in treating coronavirus diseases

Coronaviruses identified in two species of Sri Lankan bats

Single-dose of COVID-19 mRNA vaccine reduces symptom duration

Birthday parties may have boosted infection rates at the height of the COVID-19 pandemic

New tool exposes deeply entrenched inequities in COVID-19 outcomes

Clinicians report cases of rare neurological disorder following COVID-19 vaccination

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News